The global prevalence of atrial fibrillation (AF) has increased substantially over the past
three decades and is currently approximately 60 million cases. Incident AF and its clinical …

Atrial fibrillation affects almost 60 million adults worldwide. Atrial fibrillation is associated
with a high risk of cardiovascular morbidity and death as well as with social, psychological …

Background Previous atrial fibrillation screening trials have highlighted the need for more
targeted approaches. We did a pragmatic study to evaluate the effectiveness of an artificial …

Background: The role of epicardial fat (eFat)-derived extracellular vesicles (EVs) in the
pathogenesis of atrial fibrillation (AF) has never been studied. We tested the hypothesis that …

Digital smart devices have the capability of detecting atrial fibrillation (AF), but the efficacy of
this type of digital screening has not been directly compared to usual care for detection of …

Importance The comparative effectiveness of rivaroxaban and apixaban, the most frequently
prescribed oral anticoagulants for ischemic stroke prevention in patients with atrial …

Atrial fibrillation is a common heart rhythm disorder that leads to an increased risk for stroke
and heart failure. Atrial fibrillation is a complex disease with both environmental and genetic …

Objective To determine AF prevalence and gaps in atrial fibrillation (AF) awareness and
management in China. Methods We conducted a community-based survey of 47 841 adults …

Importance Atrial fibrillation (AF) is the most common heart rhythm disturbance, continues to
increase in incidence, and results in significant morbidity and mortality. The marine omega-3 …

Background: The randomized EAST-AFNET4 (Early Treatment of Atrial Fibrillation for Stroke
Prevention Trial–Atrial Fibrillation Network) demonstrated that early rhythm control (ERC) …